Literature DB >> 25592232

Effects of nicotinamide N-methyltransferase on PANC-1 cells proliferation, metastatic potential and survival under metabolic stress.

Tao Yu1, Yong-Tao Wang, Pan Chen, Yu-Hua Li, Yi-Xin Chen, Hang Zeng, Ai-Ming Yu, Min Huang, Hui-Chang Bi.   

Abstract

BACKGROUND: Aberrant expression of Nicotinamide N-methyltransferase (NNMT) has been reported in pancreatic cancer. However, the role of NNMT in pancreatic cancer development remains elusive. Therefore, the present study was to investigate the impact of NNMT on pancreatic cancer cell proliferation, metastatic potential and survival under metabolic stress.
METHODS: Pancreatic cancer cell line PANC-1 was transfected with NNMT expression plasmid or small interfering RNA of NNMT to overexpress or knockdown intracellular NNMT expression, respectively. Rate of cell proliferation was monitored. Transwell migration and matrigel invasion assays were conducted to assess cell migration and invasion capacity. Resistance to glucose deprivation, sensitivity to glycolytic inhibition, mitochondrial inhibtion and resistance to rapamycin were examined to evaluate cell survival under metabolic stress.
RESULTS: NNMT silencing markedly reduced cell proliferation, whereas NNMT overexpression promoted cell growth moderately. Knocking down NNMT also significantly suppressed the migration and invasion capacities of PANC-1 cells. Conversely, NNMT upregulation enhanced cell migration and invasion capacities. In addition, NNMT knockdown cells were much less resistant to glucose deprivation and rapamycin as well as glycolytic inhibitor 2-deoxyglucose whereas NNMT-expressing cells showed opposite effects although the effects were not so striking.
CONCLUSIONS: These data sugguest that NNMT plays an important role in PANC-1 cell proliferation, metastatic potential and survival under metabolic stress.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25592232     DOI: 10.1159/000369731

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  23 in total

1.  Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation.

Authors:  Riccardo Seta; Marco Mascitti; Roberto Campagna; Davide Sartini; Stefania Fumarola; Andrea Santarelli; Michele Giuliani; Monia Cecati; Lorenzo Lo Muzio; Monica Emanuelli
Journal:  Clin Oral Investig       Date:  2018-06-07       Impact factor: 3.573

2.  Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT).

Authors:  Nicolas Babault; Abdellah Allali-Hassani; Fengling Li; Jie Fan; Alex Yue; Kevin Ju; Feng Liu; Masoud Vedadi; Jing Liu; Jian Jin
Journal:  J Med Chem       Date:  2018-01-31       Impact factor: 7.446

3.  Nicotinamide N-methyltransferase: a potential biomarker for worse prognosis in gastric carcinoma.

Authors:  Chen Chen; Xin Wang; Xing Huang; Hongmei Yong; Jiajia Shen; Qi Tang; Jin Zhu; Jian Ni; Zhenqing Feng
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

Review 4.  Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme.

Authors:  Pavlos Pissios
Journal:  Trends Endocrinol Metab       Date:  2017-03-11       Impact factor: 12.015

5.  Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.

Authors:  Anna Reustle; Lena-Sophie Menig; Patrick Leuthold; Ute Hofmann; Viktoria Stühler; Christian Schmees; Michael Becker; Mathias Haag; Verena Klumpp; Stefan Winter; Florian A Büttner; Steffen Rausch; Jörg Hennenlotter; Falko Fend; Marcus Scharpf; Arnulf Stenzl; Jens Bedke; Matthias Schwab; Elke Schaeffeler
Journal:  Clin Transl Med       Date:  2022-06

6.  1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis.

Authors:  Agnieszka Blazejczyk; Marta Switalska; Stefan Chlopicki; Andrzej Marcinek; Jerzy Gebicki; Marcin Nowak; Anna Nasulewicz-Goldeman; Joanna Wietrzyk
Journal:  J Exp Clin Cancer Res       Date:  2016-07-13

7.  The Poly (ADP-Ribose) Polymerase Inhibitor Veliparib and Radiation Cause Significant Cell Line Dependent Metabolic Changes in Breast Cancer Cells.

Authors:  Vijesh J Bhute; Yan Ma; Xiaoping Bao; Sean P Palecek
Journal:  Sci Rep       Date:  2016-11-04       Impact factor: 4.379

8.  The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice.

Authors:  Agnieszka Denslow; Marta Switalska; Marcin Nowak; Magdalena Maciejewska; Stefan Chlopicki; Andrzej Marcinek; Jerzy Gebicki; Joanna Wietrzyk
Journal:  BMC Cancer       Date:  2017-03-07       Impact factor: 4.430

9.  Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior.

Authors:  Aaron Mobley; Shizhen Zhang; Jolanta Bondaruk; Yan Wang; Tadeusz Majewski; Nancy P Caraway; Li Huang; Einav Shoshan; Guermarie Velazquez-Torres; Giovanni Nitti; Sangkyou Lee; June Goo Lee; Enrique Fuentes-Mattei; Daniel Willis; Li Zhang; Charles C Guo; Hui Yao; Keith Baggerly; Yair Lotan; Seth P Lerner; Colin Dinney; David McConkey; Menashe Bar-Eli; Bogdan Czerniak
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

10.  Expression profile and prognostic value of NNMT in patients with pancreatic cancer.

Authors:  Yong Xu; Ping Liu; Dong-Hui Zheng; Nan Wu; Lun Zhu; Changying Xing; Jin Zhu
Journal:  Oncotarget       Date:  2016-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.